Scopus BioPharma - M&A Summary and Business Overview

Life ScienceCompany

Scopus BioPharma M&A Summary

Scopus BioPharma has acquired 1 company, including 1 in the last 5 years.

Scopus BioPharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Scopus BioPharma Business Overview

Where is Scopus BioPharma headquartered?

Scopus BioPharma is headquartered in New York, New York.

What is Scopus BioPharma’s revenue?

Scopus BioPharma disclosed revenue of 12M USD for 2022 and 28M USD for 2021.

How many employees does Scopus BioPharma have?

Scopus BioPharma has 13 employees.

What sector is Scopus BioPharma in?

Scopus BioPharma is a life science company.

When was Scopus BioPharma founded?

Scopus BioPharma was founded in 2017.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Scopus BioPharma

Scopus BioPharma, Inc.

420 Lexington Avenue,
New York, New York 10170
United States,
(212) 479-2513
www.scopusbiopharma.com

Scopus BioPharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve its mission, the company seeks to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Scopus BioPharma was formed in 2017 and is based in New York City.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - 1 - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Olimmune, Inc. 2021-06-30 - Add-on Acquisition
Los Angeles, California · www.olimmune.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  California 1 - - -
Total 1 - - -

 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.